Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04130737 · ClinicalTrials.gov registry record · NA

TORUS 2 IDE Clinical Study

A NA study of Peripheral Arterial Disease, sponsored by Endologix.

Active
Registry status
NA
Development phase
188
Enrollment target
20
Study locations

NCT04130737 is a NA study of Peripheral Arterial Disease that is active but no longer recruiting, run by Endologix. The registered enrollment target is 188 participants, below the 4,204-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (96% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04130737, a NA study of Peripheral Arterial Disease, is active but no longer recruiting, sponsored by Endologix.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
188 participants
Enrollment target
20
Study locations

Study Summary

The primary objective of the TORUS 2 IDE Clinical Study is to evaluate the safety and effectiveness of the TORUS Stent Graft System in the treatment of obstructive atherosclerotic lesions of the native SFA or the superficial femoral and/or proximal popliteal arteries.

Conditions Studied

Peripheral Arterial Disease

Interventions

  • DEVICE TORUS Stent Graft System

Study Locations (20)

Arizona

  • Southwest CVA - Mesa
  • Vascular Heart & Lung Associates - Mesa
  • Phoenix Cardiovascular Research Group - Phoenix
  • Yuma Cardiology Associates - Yuma

Florida

  • First Coast Cardiovascular Institute - Jacksonville
  • Palm Vascular Centers - Miami Beach
  • Coastal Vascular & Interventional - Pensacola
  • Florida Cardiology - Winter Park

Michigan

  • McLaren Bay Region - Bay City
  • Michigan Vascular Center - Flint
  • Eastlake Cardiovascular - Roseville

California

  • Bay Area Vein & Vascular Institute - Burlingame
  • UCSF - San Francisco

Arkansas

  • Arkansas Heart - Little Rock

Colorado

  • Rocky Mountain Regional VAMC - Aurora

Connecticut

  • The Vascular Experts - Darien

Illinois

  • AMITA Health - Elk Grove

Trial Details

FieldValue
Enrollment Target 188 participants
Start Date 2019-10-31
Est. Completion 2024-12-24
Phase NA

Sponsor

Endologix

17 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04130737

The ClinicalTrials.gov registry entry for NCT04130737 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,204-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (96% lower). The listed sponsor is Endologix, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which TORUS Stent Graft System is the first listed.

NCT04130737 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Arizona, Florida, Michigan.

Frequently Asked Questions

What is clinical trial NCT04130737 about?

NCT04130737 is a clinical study titled "TORUS 2 IDE Clinical Study". The primary objective of the TORUS 2 IDE Clinical Study is to evaluate the safety and effectiveness of the TORUS Stent Graft System in the treatment of obstructive atherosclerotic lesions of the native SFA or the superficial femoral and/or proximal popliteal arteries.

What is the current status of trial NCT04130737?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 188 participants. The study started on 2019-10-31. Estimated completion is 2024-12-24.

What conditions does trial NCT04130737 study?

This clinical trial studies the following conditions: Peripheral Arterial Disease.

What interventions are being tested in trial NCT04130737?

The interventions under investigation include: TORUS Stent Graft System (DEVICE).

Who is sponsoring clinical trial NCT04130737?

This trial is sponsored by Endologix, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04130737 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Peripheral Arterial Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Peripheral Arterial Disease

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.